表紙
市場調查報告書

心臟去顫器的全球市場的預測:2019年∼2029年 - 植入式心臟整流去顫器、體外去顫器

Global Defibrillators Market Forecast 2019-2029

出版商 Visiongain Ltd 商品編碼 430724
出版日期 內容資訊 英文 179 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
心臟去顫器的全球市場的預測:2019年∼2029年 - 植入式心臟整流去顫器、體外去顫器 Global Defibrillators Market Forecast 2019-2029
出版日期: 2018年12月19日內容資訊: 英文 179 Pages
簡介

全球心臟去顫器的市場,預計從2017年到2029年,以6.1%的年複合成長率 (CAGR) 擴大。在2018年中,植入式心臟整流去顫器市場區隔佔了心臟去顫器市場的77%。

本報告提供全球心臟去顫器的市場調查,市場及產品概要,心臟去顫器的演進,市場的各種影響因素分析,各產品、終端用戶、主要國家趨勢與市場規模的變化與預測,主要企業簡介等資訊。

第1章 報告概要

第2章 簡介:心臟去顫器市場

  • 市場定義
  • 心臟去顫器的演進

第3章 全球市場的預測

  • 全球市場的預測
  • 各產品的預測
  • 市場動態

第4章 全球市場的預測:各產品

  • 植入式心臟整流去顫器 (ICD)
    • 經靜脈ICD (T-ICD)
    • 皮下ICD (S-ICD)
  • 體外去顫器
    • 手動
    • AED
    • 穿戴式

第5章 全球市場的預測:各終端用戶

  • 醫院、心臟中心
  • 院前救護
  • 公共存取
  • 居家護理
  • 其他

第6章 主要國家市場

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
  • 其他地區
    • 南美
    • 中東、非洲

第7章 主要企業

  • Medtronic PLC
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Abbott Laboratories
  • LivaNova PLC
  • Zoll Medical Corporation
  • Physio Control, Inc.
  • Cardiac Science Corporation
  • 日本光電
  • Philips Healthcare

第8章 SWOT分析、PEST分析

第9章 總論、建議

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0348

Title:
GLOBAL DEFIBRILLATORS MARKET FORECAST 2019-2029
External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators.

The global defibrillators market is expected to grow at a CAGR of 5.2% from 2017-2022. The market is expected to grow at a CAGR of 6.1% from 2017 to 2029. In 2018, the Implantable Cardioverter Defibrillators segment held 77% of the global defibrillators market.

How this report will benefit you:

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report, you find 179-page report you will receive 74 tables and 125 figures - all unavailable elsewhere.

The 179-page report provides clear detailed insight into the global defibrillators market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Defibrillators Market forecast 2019-2029

Global Defibrillators market forecast by product:

Implantable Cardioverter Defibrillators (ICDs)

  • Transvenous ICDs (T-ICDs)
    • Single-Chamber ICDs
    • Dual-Chamber ICDs
    • Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
  • Subcutaneous ICDs (S-ICDs)

External Defibrillators

  • Manual External Defibrillators
  • Automated External Defibrillators (AEDs)
    • Semi-Automated External Defibrillators
    • Fully-Automated External Defibrillators
  • Wearable Cardioverter Defibrillators (WCDs)

Global Defibrillators market forecast by end-user:

  • Hospitals and Cardiac Centers
  • Pre-hospital Services
  • Public Access
  • Home Care
  • Other-End User

Global Defibrillators National Market forecast 2019-2029, covering:

  • North America:
    • US
    • Canada
  • Europe:
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific:
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World:
    • Latin America
    • Middle East
    • Africa

Analysis of the key factors driving and restraining the growth of the defibrillators market.

Assessment of selected leading companies, examining recent performance and outlooks:

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Nihon Kohden Corporation
  • Phillips Healthcare
  • Physio Control Inc.
  • Zoll Medical Corporation

Visiongain's study is intended for anyone requiring commercial analyses for the Global Defibrillators Market and leading companies. You find data, trends and predictions.

Buy our report today Global Defibrillators Market Forecast 2019-2029: External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Defibrillators Market Overview
  • 1.2. Global Defibrillators Market Segmentation
  • 1.3. Why You Should Read This Report
  • 1.4. How This Report Delivers
  • 1.5. Key Questions Answered by This Analytical Report
  • 1.6. Who is This Report For?
  • 1.7. Methodology
    • 1.7.1. Primary Research
    • 1.7.2. Secondary Research
    • 1.7.3. Market Evaluation & Forecasting Methodology
  • 1.8. Frequently Asked Questions (FAQ)
  • 1.9. Associated Visiongain Reports
  • 1.10. About Visiongain

2. Introduction to the Defibrillators Market

  • 2.1. Defibrillators Market Definition
  • 2.2. Evolution of Defibrillators
    • 2.2.1. Snapshot: Evolution of Defibrillators
    • 2.2.2. History of Defibrillators
    • 2.2.3. Currently Available Defibrillators
    • 2.2.4. Future of Defibrillators

3. Global Defibrillators Market Forecast 2019-2029

  • 3.1. Global Defibrillators Market Forecast to 2019-2029
  • 3.2. Global Defibrillators Market Forecast by Product 2019-2029
  • 3.3. Global Defibrillators Market Dynamics, 2018

4. Global Defibrillators Market by Product: Market Forecast 2019-2029

  • 4.1. Implantable Cardioverter Defibrillators (ICDs) Market
    • 4.1.1. Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
    • 4.1.2. Subcutaneous Implantable Cardioverter Defibrillators (S-ICD)
  • 4.2. External Defibrillators Market
    • 4.2.1. Manual External Defibrillators Market
    • 4.2.2. Automated External Defibrillators (AEDs) Market
    • 4.2.3. Wearable Cardioverter Defibrillators (WCDs)

5. Global Defibrillators Market by End-User: Market Forecast 2019-2029

  • 5.1. Hospitals and Cardiac Centers Market
  • 5.2. Pre-hospital Market
  • 5.3. Public Access Sector Market
  • 5.4. Home Care Market
  • 5.5. Other End Use Sectors Market

6. Leading National Markets Forecast 2019-2029

  • 6.1. North America Defibrillators Market Forecast 2019-2029
    • 6.1.1. U.S. Defibrillators Market Forecast 2019-2029
    • 6.1.2. Canada Defibrillators Market Forecast 2019-2029
  • 6.2. Europe Defibrillators Market Forecast 2019-2029
    • 6.2.1. UK Defibrillators Market Forecast 2019-2029
    • 6.2.2. France Defibrillators Market Forecast 2019-2029
    • 6.2.3. Germany Defibrillators Market Forecast 2019-2029
    • 6.2.4. Italy Defibrillators Market Forecast 2019-2029
    • 6.2.5. Spain Defibrillators Market Forecast 2019-2029
    • 6.2.6. Rest of Europe Defibrillators Market Forecast 2019-2029
  • 6.3. Asia-Pacific Defibrillators Market Forecast 2019-2029
    • 6.3.1. China Defibrillators Market Forecast 2019-2029
    • 6.3.2. Japan Defibrillators Market Forecast 2019-2029
    • 6.3.3. India Defibrillators Market Forecast 2019-2029
    • 6.3.4. Rest of APAC Defibrillators Market Forecast 2019-2029
  • 6.4. Rest of the World (RoW) Defibrillators Market Forecast 2019-2029
    • 6.4.1. Latin America Defibrillators Market Forecast 2019-2029
    • 6.4.2. Middle East and Africa Defibrillators Market Forecast 2019-2029

7. Leading Companies in the Defibrillators Market

  • 7.1. Medtronic PLC: Company Information
    • 7.1.1. Medtronic PLC: Business Overview
    • 7.1.2. Medtronic PLC: Financial Overview
    • 7.1.3. Medtronic PLC: Product Portfolio
    • 7.1.4. Medtronic PLC: Recent Developments
    • 7.1.5. SWOT Analysis
  • 7.2. Boston Scientific Corporation: Company Information
    • 7.2.1. Boston Scientific Corporation: Business Overview
    • 7.2.2. Boston Scientific Corporation: Financial Overview
    • 7.2.3. Boston Scientific Corporation: Product Portfolio
    • 7.2.4. Boston Scientific Corporation: Recent Developments
    • 7.2.5. Boston Scientific Corporation: SWOT Analysis
  • 7.3. Biotronik SE & Co. KG: Company Information
    • 7.3.1. Biotronik SE & Co. KG: Business Overview
    • 7.3.2. Biotronik SE & Co. KG: Product Portfolio
    • 7.3.3. Biotronik SE & Co. KG: Recent Developments
  • 7.4. Abbott Laboratories: Company Information
    • 7.4.1. Abbott Laboratories: Business Overview
    • 7.4.2. Abbott Laboratories: Financial Overview
    • 7.4.3. Abbott Laboratories: Product Portfolio
    • 7.4.4. Abbott Laboratories: Recent Developments
    • 7.4.5. Abbott Laboratories: SWOT Analysis
  • 7.5. LivaNova PLC: Company Information
    • 7.5.1. LivaNova PLC: Business Overview
    • 7.5.2. LivaNova PLC: Financial Overview
    • 7.5.3. LivaNova PLC: Product Portfolio
    • 7.5.4. LivaNova PLC: Recent Developments
  • 7.6. Zoll Medical Corporation: Company Information
    • 7.6.1. Zoll Medical Corporation: Business Overview
    • 7.6.2. Zoll Medical Corporation: Financial Overview
    • 7.6.3. Zoll Medical Corporation: Product Portfolio
    • 7.6.4. Zoll Medical Corporation: Recent Developments
    • 7.6.5. Zoll Medical Corporation: SWOT Analysis
  • 7.7. Physio Control, Inc.: Company Information
    • 7.7.1. Physio Control, Inc.: Business Overview
    • 7.7.2. Physio Control, Inc.: Product Portfolio
    • 7.7.3. Physio Control, Inc.: Recent Developments
  • 7.8. Cardiac Science Corporation: Company Information
    • 7.8.1. Cardiac Science Corporation: Business Overview
    • 7.8.2. Cardiac Science Corporation: Product Portfolio
    • 7.8.3. Cardiac Science Corporation: Recent Developments
  • 7.9. Nihon Kohden Corporation: Company Information
    • 7.9.1. Nihon Kohden Corporation: Business Overview
    • 7.9.2. Nihon Kohden Corporation: Financial Overview
    • 7.9.3. Nihon Kohden Corporation: Product Portfolio
    • 7.9.4. Nihon Kohden Corporation: Recent Developments
  • 7.10. Philips Healthcare: Company Information
    • 7.10.1. Philips Healthcare: Business Overview
    • 7.10.2. Philips Healthcare: Financial Overview
    • 7.10.3. Philips Healthcare: Product Portfolio
    • 7.10.4. Philips Healthcare: Recent Developments
    • 7.10.5. Philips Healthcare: SWOT Analysis

8. Defibrillators Market Dynamics: SWOT and PEST Analysis

  • 8.1. SWOT Analysis
    • 8.1.1. Global Defibrillator Market Drivers
      • 8.1.1.1. Availability of Technologically Advanced Defibrillators
      • 8.1.1.2. Rapidly Growing Aging Population Leading to High Risk of Cardiovascular Diseases
      • 8.1.1.3. Growing Incidence of Cardiovascular Diseases
      • 8.1.1.4. Increasing Awareness and Training programmes Related to Defibrillators
    • 8.1.2. Global Defibrillator Market Restraints
      • 8.1.2.1. Concerns Associated with the Use of Defibrillators
      • 8.1.2.2. Increasing Pricing Pressure on Manufacturers
      • 8.1.2.3. Product Recalls
    • 8.1.3. Global Defibrillator Market Opportunity
      • 8.1.3.1. Focus on Emerging Markets
    • 8.1.4. Global Defibrillator Market Trend
      • 8.1.4.1. Mergers and Acquisitions
      • 8.1.4.2. Development of ICDs and CRT-Ds with full-body MRI scans
  • 8.2. PEST Analysis
    • 8.2.1. Political
    • 8.2.2. Economic
    • 8.2.3. Social
    • 8.2.4. Technological

9. Conclusions and Recommendations

  • 9.1. The Global Defibrillator Market in 2017 and 2029
    • 9.1.1. Current Leading Defibrillators Segments
    • 9.1.2. Leading Defibrillators Companies
    • 9.1.3. Leading Regional Markets
  • 9.2. Global Defibrillators Market Forecast 2017-2029
  • 9.3. The Future of the Defibrillators Market?

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain Report Evaluation Form

List of Tables

  • Table 3.1: Global Defibrillator Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 3.2: Global Defibrillator Market Forecast by Product: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 3.3: Defibrillator Market Forecast by Region: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 3.4: Global Defibrillators Market Dynamics 2018
  • Table 4.1: Global Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 4.2: Global Implantable Cardioverter Defibrillators (ICDs) Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 4.3: Global Transvenous Implantable Cardioverter Defibrillator (T-ICD) Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 4.4: Global Single- Chamber Implantable Cardioverter Defibrillator Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 4.5: Global Dual- Chamber Implantable Cardioverter Defibrillator Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 4.6: Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Forecast 2017-2029($bn, AGR %, CAGR %)
  • Table 4.7: Global Subcutaneous Implantable Cardioverter Defibrillators (S-ICD) Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 4.8: Global External Defibrillator Market Forecast 2017-2029 by Product ($bn, AGR %, CAGR %)
  • Table 4.9: Global Manual External Defibrillators Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 4.10: Global Automated External Defibrillators (AEDs) Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 4.11: Global Wearable Cardioverter External Defibrillators (WCDs) Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 5.1: Global Defibrillator Market by End-User 2017-2029 ($bn, AGR %, CAGR %)
  • Table 5.2: Global Hospitals and Cardiac Centers Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 5.3: Global Pre-Hospitals Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 5.4: Global Public Access Sector Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 5.5: Global Home Care Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 5.6: Global Other End User Market Forecast 2017-2029 ($bn, AGR %, CAGR %)
  • Table 6.1: Defibrillator Market Forecast Segmented by Regional Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.2: North American Defibrillators Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.3: U.S. Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.4: Canada Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.5: European Defibrillators Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.6: U.K. Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.7: France Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.8: Germany Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.9: Italy Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.10: Spain Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.11: Rest of Europe Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.12: Asia-Pacific Defibrillators Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.13: China Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.14: Japan Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.15: India Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.16: Rest of APAC Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.17: Rest of the World Defibrillators Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.18: Latin America Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 6.19: Middle East & Africa Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029
  • Table 7.1: Medtronic PLC: Company Information
  • Table 7.2: Medtronic PLC: Product Portfolio
  • Table 7.3: Medtronic PLC: Recent Developments
  • Table 7.4: Medtronic PLC: Expansion
  • Table 7.5: Boston Scientific Corporation: Company Information
  • Table 7.6: Boston Scientific Corporation: Product Portfolio
  • Table 7.7: Boston Scientific Corporation: Recent Developments
  • Table 7.8: Biotronik SE & CO. KG: Company Information
  • Table 7.9: Biotronik SE & CO. KG: Product Portfolio
  • Table 7.10: Biotronik SE & CO. KG: Recent Developments
  • Table 7.11: Abbott Laboratories: Company Information
  • Table 7.12: Abbott Laboratories: Product Category
  • Table 7.13: Abbott Laboratories: Recent Developments
  • Table 7.14: LivaNova PLC: Company Information
  • Table 7.15: LivaNova PLC: Product Portfolio
  • Table 7.16: LivaNova PLC: Recent Developments
  • Table 7.17: Zoll Medical Corporation: Company Information
  • Table 7.18: Zoll Medical Corporatio: Product Category
  • Table 7.19: Zoll Medical Corporatio: Recent Developments
  • Table 7.20: Physio Control, Inc.: Company Information
  • Table 7.21: Physio Control, Inc.: Product Portfolio
  • Table 7.22: Physio Control, Inc.: Recent Developments
  • Table 7.23: Cardiac Science Corporation: Company Information
  • Table 7.24: Cardiac Science Corporation: Product Portfolio
  • Table 7.25: Cardiac Science Corporation: Recent Developments
  • Table 7.26: Nihon Kohden Corporation: Company Information
  • Table 7.27: Nihon Kohden Corporation: Product Portfolio
  • Table 7.28: Nihon Kohden Corporation: Recent Developments
  • Table 7.29: Philips Healthcare: Company Information
  • Table 7.30: Philips Healthcare: Product Portfolio
  • Table 7.31: Philips Healthcare: Recent Developments
  • Table 8.1: List of Product Recalls
  • Table 8.2: List of Mergers and Acquisitions in the Defibrillators Market
  • Table 8.3: MRI-Conditional ICDs and CRT-Ds Approved in 2016

List of Figures

  • Figure 1.1: Global Defibrillators Market Segmentation Overview
  • Figure 2.1: Snapshot: Evolution of Defibrillators
  • Figure 3.1: Global Defibrillator Market Forecast: Revenue ($bn), AGR (%), 2017-2029
  • Figure 3.2: Global Defibrillator Market by Product: 2017-2029 ($bn)
  • Figure 3.3: Defibrillator Market by Region: 2017-2029($bn, AGR %)
  • Figure 4.1: Global Defibrillator Market: 2017-2029 ($bn)
  • Figure 4.2: Global Defibrillator Market by Product: Market Share (%), 2018
  • Figure 4.3: Global Defibrillator Market by Product: Market Share (%), 2023
  • Figure 4.4: Global Defibrillator Market by Product: Market Share (%), 2029
  • Figure 4.5: Global Implantable Cardioverter Defibrillators Market: 2017-2029 ($bn, AGR %)
  • Figure 4.6: Global Implantable Cardioverter Defibrillators (ICDs) Market by Sub Segment: Market Share (%), 2018
  • Figure 4.7: Global Implantable Cardioverter Defibrillators (ICDs) Market by Sub Segment: Market Share (%), 2023
  • Figure 4.8: Global Implantable Cardioverter Defibrillators (ICDs) Market by Sub Segment: Market Share (%), 2029
  • Figure 4.9: Global Transvenous Implantable Cardioverter Defibrillators Market: 2017-2029 ($bn, AGR %)
  • Figure 4.10: Global Transvenous Implantable Cardioverter Defibrillator (T-ICD) Market by Sub Segment: Market Share (%), 2018
  • Figure 4.11: Global Transvenous Implantable Cardioverter Defibrillator (T-ICD) Market by Sub Segment: Market Share (%), 2023
  • Figure 4.12: Global Transvenous Implantable Cardioverter Defibrillator (T-ICD) Market by Sub Segment: Market Share (%), 2029
  • Figure 4.13: Global Single-Chamber Implantable Cardioverter Defibrillator Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 4.14: Global Dual-Chamber Implantable Cardioverter Defibrillator Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 4.15: Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 4.16: Global Subcutaneous Implantable Cardioverter Defibrillators (CRT-Ds) Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 4.17: Global External Defibrillators Market Forecast 2017-2029 ($bn, AGR %)
  • Figure 4.18: Global External Defibrillators Market by Sub Segment: Market Share (%), 2018
  • Figure 4.19: Global External Defibrillators Market by Sub Segment: Market Share (%), 2023
  • Figure 4.20: Global External Defibrillators Market by Sub Segment: Market Share (%), 2029
  • Figure 4.21: Global Manual External Defibrillators Forecast 2017-2029 ($bn, AGR %)
  • Figure 4.22: Global Automated External Defibrillators Market by Sub Segment: Market Share (%), 2018
  • Figure 4.23: Global Automated External Defibrillators Market by Sub Segment: Market Share (%), 2023
  • Figure 4.24: Global Automated External Defibrillators Market by Sub Segment: Market Share (%), 2029
  • Figure 4.25: Global Wearable Cardioverter External Defibrillators Forecast 2017-2029 ($bn, AGR %)
  • Figure 5.1: Global Defibrillators Market by End-User: 2017-2029 ($bn)
  • Figure 5.2: Global Defibrillators Market by End User: Market Share (%), 2018
  • Figure 5.3: Global Defibrillators Market by End User: Market Share (%), 2023
  • Figure 5.4: Global Defibrillators Market by End User: Market Share (%), 2029
  • Figure 5.5: Global Hospitals and Cardiac Centers Defibrillators Market Forecast 2017- 2029 ($bn, AGR %)
  • Figure 5.6: Global Pre-Hospitals Defibrillators Market Forecast 2017-2029 ($bn, AGR %)
  • Figure 5.7: Global Public Access Sector Defibrillators Market Forecast 2017-2029 ($bn, AGR %)
  • Figure 5.8: Global Home Care Defibrillator Market Forecast 2017-2029 ($bn, AGR %)
  • Figure 5.9: Global Other End User Market Forecast 2017-2029 ($bn, AGR %)
  • Figure 6.1: Defibrillators Market Forecast Segmented by Regional Market: 2017-2029 ($bn)
  • Figure 6.2: Global Defibrillator Market by Region: Market Share (%), 2018
  • Figure 6.3: Global Defibrillator Market by Region: Market Share (%), 2023
  • Figure 6.4: Global Defibrillator Market by Region: Market Share (%), 2029
  • Figure 6.5: North American Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.6: North American Defibrillators Market Forecast Segmented by National Market: 2017-2029 ($bn)
  • Figure 6.7: North American Defibrillator Market by Country: Market Share (%), 2018
  • Figure 6.8: North American Defibrillator Market by Country: Market Share (%), 2023
  • Figure 6.9: North American Defibrillator Market by Country: Market Share (%), 2029
  • Figure 6.10: U.S. Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.11: Canada Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.12: European Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.13: European Defibrillators Market Forecast Segmented by National Market: 2017-2029 ($bn)
  • Figure 6.14: European Defibrillators Market by Country: Market Share (%), 2018
  • Figure 6.15: European Defibrillators Market by Country: Market Share (%), 2023
  • Figure 6.16: European Defibrillators Market by Country: Market Share (%), 2029
  • Figure 6.17: U.K. Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.18: France Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.19: Germany Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.20: Italy Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.21: Spain Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.22: Rest of Europe Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.23: Asia-Pacific Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.24: Asia-Pacific Defibrillators Market Forecast Segmented by National Market: 2017-2029 ($bn)
  • Figure 6.25: APAC Defibrillators Market by Country: Market Share (%), 2018
  • Figure 6.26: APAC Defibrillators Market by Country: Market Share (%), 2023
  • Figure 6.27: APAC Defibrillators Market by Country: Market Share (%), 2029
  • Figure 6.28: China Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.29: Japan Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.30: India Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.31: Rest of APAC Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.32: Rest of the World Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.33: Rest of the World Defibrillators Market Forecast: 2017-2029 ($bn)
  • Figure 6.34: RoW Defibrillator Market by Region: Market Share (%), 2018
  • Figure 6.35: RoW Defibrillator Market by Region: Market Share (%), 2023
  • Figure 6.36: RoW Defibrillator Market by Region: Market Share (%), 2029
  • Figure 6.37: Latin American Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 6.38: Middle East & Africa Defibrillators Market Forecast: 2017-2029 ($bn, AGR %)
  • Figure 7.1: Medtronic PLC: Financial Overview 2014-2018
  • Figure 7.2: Medtronic PLC: Segment Overview - 2018
  • Figure 7.3: Medtronic PLC: Geographical Overview - 2018
  • Figure 7.4: Medtronic PLC: SWOT Analysis
  • Figure 7.5: Boston Scientific Corporation: Financial Overview 2013-2017
  • Figure 7.6: Boston Scientific Corporation: Segment Overview - 2018
  • Figure 7.7: Boston Scientific Corporation: Geographic Overview - 2018
  • Figure 7.8: Boston Scientific Corporation: SWOT Analysis
  • Figure 7.9: Abbott Laboratories: Financial Overview 2013-2017
  • Figure 7.10: Abbott Laboratories: Segment Overview - 2018
  • Figure 7.10: Abbott Laboratories: Geographic Overview - 2018
  • Figure 7.12: Abbott Laboratories: SWOT Analysis
  • Figure 7.13: LivaNova PLC: Financial Overview 2013-2017
  • Figure 7.14: LivaNova PLC: Segment Overview - 2018
  • Figure 7.15: LivaNova PLC: Geographic Overview - 2018
  • Figure 7.16: Zoll Medical Corporation: Financial Overview
  • Figure 7.17: Zoll Medical Corporation: SWOT Analysis
  • Figure 7.18: Nihon Kohden Corporation: Financial Overview 2013-2017
  • Figure 7.19: Nihon Kohden Corporation: Segment Overview - 2018
  • Figure 7.20: Nihon Kohden Corporation Geographic Overview - 2018
  • Figure 7.21: Philips Healthcare: Financial Overview 2013 - 2017
  • Figure 7.22: Nihon Kohden Corporation: Segment Overview - 2018
  • Figure 7.23: Nihon Kohden Corporation Geographic Overview - 2018
  • Figure 7.24: Philips Healthcare: SWOT Analysis
  • Figure 8.1: Number of Cardiovascular Deaths (Million) by Region (2015 to 2030)
  • Figure 9.1: Global Defibrillator Market: 2017-2029 ($bn, AGR %)
  • Figure 9.2: Global Defibrillator Market by Product: 2017-2029 ($bn)
  • Figure 9.3: Defibrillator Market by Region: 2017-2029 ($bn)

COMPANIES LISTED:

  • Abbott Laboratories
  • ADS, Inc.
  • Air Force
  • Alere Inc.
  • American Heart Association (AHA)
  • Apama Medical Inc.
  • Asahi Kasei Group Company
  • Aska Equipments Ltd.
  • Augmenix, Inc.
  • Aurora Capital Group
  • Aurora Resurgence
  • Aziyo
  • Badger State Sheriffs' Association (BSSA)
  • Barcelona City Council
  • Bavarian Red Cross
  • BIOTRONIK
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • British Red Cross
  • Caisson Interventional, LLC.
  • Cardiac Science Corporation
  • China Food and Drug Administration
  • Crospon
  • Cyberonics Inc.
  • Department of Education, UK
  • European Heart Rhythm Association
  • Farong Shen in Zhejiang Lucheng Hospital
  • Groveland Fire Department
  • Health Canada
  • Heart Rhythm Society (HRS)
  • HEART UK
  • HeartSine Technologies
  • ImThera Medical
  • Japanese Ministry of Health, Labour and Welfare
  • Johns Hopkins University
  • Koninklijke Philips N.V.
  • Lek
  • Life-Assist, Inc.
  • Lippert Components, Inc.
  • LivaNova Plc
  • Mazor Robotics
  • Medtronic Emergency Response Systems, Inc.
  • Medtronic plc
  • Metrax GmbH
  • Metrax GmbH
  • MicroPort Scientific
  • MicroPort Scientific Corporation
  • MicroPort Sorin CRM (Shanghai) Co. Ltd
  • Mountain Rescue Association of Slovenia (MRAS)
  • National Health Service
  • National Taxi Association
  • Nihon Kohden
  • Nihon Kohden Corporation
  • Nutrino
  • nVision Medical Corporation
  • Philips Healthcare
  • Physio-Control, Inc.
  • Progetti Srl
  • Promega Srl.
  • Quinton Cardiology Systems, Inc.
  • Sand Holdco Limited
  • Sand Holdco PLC
  • Saudi Heart Rhythm Society
  • Securus Medical Group, Inc.
  • Singapore Civil Defence Force (SCDF)
  • Singapore Heart Foundation
  • Smith & Nephew
  • Sorin S.p.A
  • Spacelabs Healthcare
  • St. Jude Medical, Inc.
  • Stentor, Inc.
  • Stryker Corporation
  • Symetis SA
  • TandemLife
  • The Spectranetics Corporation
  • United Nations
  • United States Food and Drugs Administration
  • US Army
  • VisionSense
  • Walmart Canada
  • Wei Hua in Beijing Fuwai Hospital
  • World Health Organization
  • World Heart Federation (WHF)
  • ZOLL Medical Corporation
Back to Top